NasdaqCM - Delayed Quote USD

Creative Medical Technology Holdings, Inc. (CELZ)

4.3200 -0.1000 (-2.26%)
At close: April 26 at 4:00 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Timothy Warbington Co-Founder, Chairman, President & CEO 429k -- 1962
Mr. Donald Dickerson Senior VP, CFO & Director 390k -- 1965

Creative Medical Technology Holdings, Inc.

211 East Osborn Road
Phoenix, AZ 85012
United States
(480) 399-2822 https://www.creativemedicaltechnology.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
4

Description

Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Corporate Governance

Creative Medical Technology Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 10, 2024 - May 14, 2024
Creative Medical Technology Holdings, Inc. Earnings Call

Related Tickers

TSOI Therapeutic Solutions International, Inc.
0.0006
+9.09%
 
VRAX Virax Biolabs Group Limited
0.6900
-1.71%
 
REVB Revelation Biosciences, Inc.
2.1800
+2.83%
 
ENSC Ensysce Biosciences, Inc.
0.5842
+1.69%
 
SPRC SciSparc Ltd.
1.3200
+4.76%
 
HOTH Hoth Therapeutics, Inc.
1.1600
0.00%
 
SONN Sonnet BioTherapeutics Holdings, Inc.
1.7700
+1.14%
 
BPTS Biophytis S.A.
8.22
0.00%
 
DRMA Dermata Therapeutics, Inc.
0.3427
-3.74%
 
GNTA Genenta Science S.p.A.
2.5900
-11.60%